Internal Medicine, Endocrinology, Diabetes, & Metabolism · Hudson, FL
NPI
1538353305
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
14100 Fivay Rd, Suite 250
Hudson, FL, 34667
Phone (727) 869-7822
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
4,422 services
Medicare patients, 2024
407
Average age 73
Drug cost, 2024
$3.3M
6,158 prescriptions
Company payments, 2025
$163K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ania E Janicka was code J0897 (injection, denosumab, 1 mg), 1,740 times for 23 patients. In total Ania E Janicka billed 4,422 services in 21 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-09-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,740 | 23 | $20.37 | $35K |
| 99214 Office E&M - Established | Office | 375 | 254 | $88.18 | $33K |
| 82962 Clinical Chemistry | Office | 279 | 193 | $3.21 | $896 |
| 95251 Test - Miscellaneous | Office | 217 | 118 | $25.79 | $5,596 |
| 99215 Office E&M - Established | Office | 189 | 126 | $120.48 | $23K |
| 99213 Office E&M - Established | Office | 89 | 69 | $57.67 | $5,132 |
| 76536 Ultrasound - Nonspecific | Office | 76 | 65 | $76.49 | $5,813 |
| 96372 Injection Administration | Office | 41 | 26 | $9.66 | $396 |
| 99204 Office E&M - New | Office | 36 | 36 | $106.04 | $3,817 |
| 99205 Office E&M - New | Office | 30 | 30 | $163.86 | $4,916 |
| 10005 Other Organ Systems | Office | 18 | 17 | $98.06 | $1,765 |
| 99231 Hospital E&M - Subsequent | Facility | 12 | 11 | $39.00 | $468 |
By year: 2022 $164K for 5,806 services; 2023 $172K for 6,599 services; 2024 $133K for 4,422 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 279 | 193 | $3.21 | $896 |
Medicare prescription drug claims, 2024
In 2024, the drug Ania E Janicka prescribed most often to Medicare patients was Ozempic (Semaglutide), with 533 prescriptions and refills. In total Ania E Janicka wrote 6,158 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 533 | 815 | 121 | $768K |
| Levothyroxine Sodium Generic | 513 | 1,355 | 157 | $5,800 |
| Jardiance Empagliflozin | 292 | 553 | 81 | $321K |
| Mounjaro Tirzepatide | 254 | 325 | 45 | $342K |
| Metformin Hcl Er Metformin Hcl | 218 | 510 | 68 | $1,502 |
| Synthroid Levothyroxine Sodium | 203 | 527 | 53 | $21K |
| Tresiba Flextouch U-100 Insulin Degludec | 198 | 420 | 56 | $105K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 184 | 347 | 37 | $230K |
| Rosuvastatin Calcium Generic | 182 | 472 | 56 | $1,285 |
| Pioglitazone Hcl Generic | 145 | 389 | 49 | $1,476 |
| Glimepiride Generic | 132 | 298 | 37 | $752 |
| Trulicity Dulaglutide | 122 | 164 | 27 | $157K |
| Metformin Hcl Generic | 118 | 317 | 38 | $986 |
| Ezetimibe Generic | 110 | 303 | 34 | $1,489 |
| Methimazole Generic | 100 | 245 | 30 | $1,116 |
Brand drugs: 3,492 claims; generic drugs: 1,966 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ania E Janicka $163K ($163K in general payments such as food, travel and fees) from 28 companies. The largest payer was Insulet Corporation with $104K.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 220 | $104K |
| Novo Nordisk Inc NVO | 40 | $23K |
| Dexcom, Inc. DXCM | 26 | $18K |
| Abbott Laboratories ABT | 38 | $17K |
| Lilly USA, LLC LLY | 9 | $182 |
| Tandem Diabetes Care, Inc. TNDM | 6 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $141 |
| Recordati_rare_diseases_inc. | 4 | $91.12 |
| Rhythm Pharmaceuticals, Inc. RYTM | 3 | $86.3 |
| Amgen Inc. AMGN | 4 | $83.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.